Skip to content

Rho(D) Antibody Screening Test (Serum)

Published: August 9, 2026Updated: August 16, 2026

This blood test checks for antibodies that may cause problems during pregnancy, specifically antibodies against the Rh(D) antigen found on red blood cells.

Quick summary

["Helps ensure safe blood compatibility for pregnancy and potential future pregnancies."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
10425-7
Short code
Trans Rhogam Vol Patient
Synonyms
Trans Rhogam Vol Patient
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Matters During Pregnancy

The Rho(D) antibody screen is important for pregnant individuals who are Rh-negative (lack the Rh(D) antigen on their red blood cells). If you develop antibodies against Rh-positive red blood cells, they can cross the placenta and attack your baby’s red blood cells, potentially leading to complications like anemia or severe blood disorders. This test helps determine if you need additional Rh immune globulin (Rho(D) immune globulin) to prevent these issues.

How the Test Works

A small blood sample is taken to check for the presence of Rh(D) antibodies in your serum. The test uses an immunoassay method to detect these antibodies, which may develop after exposure to Rh-positive blood (e.g., during pregnancy or blood transfusions).

What to Expect Before the Test

There are no special preparations needed. You may have a slight pinch when the blood is drawn, but it usually takes only a few minutes. If you’re pregnant, your healthcare provider will schedule this test early in your pregnancy to monitor for Rh incompatibility.

What the Results Mean

A positive result means you have Rh(D) antibodies in your blood. This may require further testing or treatment with Rho(D) immune globulin to protect your baby. A negative result means no antibodies are detected, but you should continue monitoring during future pregnancies.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

Rho(D) Antibody Screen

Frequently asked questions

When might I need this test?
This test is typically ordered for Rh-negative individuals during pregnancy, especially if you’ve had a previous pregnancy with a Rh-positive baby, miscarriage, or blood transfusion. Your healthcare provider may also recommend it if you have unexplained anemia or other pregnancy-related complications.
What if my test result is positive?
A positive result means you’ll likely receive Rho(D) immune globulin during your pregnancy to block any new Rh(D) antibodies from forming. This treatment helps prevent potential harm to your baby’s red blood cells. Follow-up testing may be needed to monitor antibody levels.
How often should I get this test?
If you’re Rh-negative, this test is usually done at your first prenatal visit and again at 28 weeks of pregnancy. Some providers may also check antibody levels after delivery or in subsequent pregnancies.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy